Pharmacology

Cyclosporine And Tacrolimus Combination Proves Effective In The Treatment Of Multiple Sclerosis

A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects. To achieve this, a team of scientists have combined two already approved pharmaceutical subs ...

Article - News Staff - Nov 26 2012 - 4:47pm

HUMIRA Approved In Europe For Severe Active Pediatric Crohn's Disease

The European Commission has approved  Abbott's HUMIRA® (adalimumab) for the treatment of pediatric patients aged 6 to 17 years with severe active Crohn's disease (CD) who failed, are intolerant to, or have contraindications to conventional thera ...

Article - News Staff - Nov 27 2012 - 9:00am

Chronic Myeloid Leukemia Mutation Thwarted By Ponatinib

A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial. 12 patients in a trial with chronic phase CML and the T315I mutation had a complete hematologic response (absence ...

Article - News Staff - Dec 2 2012 - 6:49pm

Merck Serono Donates 100 Millionth Tablet For Schistosomiasis Treatment

Merck Serono, a division of Merck, has donated its 100 millionth praziquantel tablet to the World Health Organization (WHO). ...

Article - News Staff - Nov 29 2012 - 12:17pm

Psychotropic Medication Prevalence In US Adolescents With Mental Disorders

A survey published in Archives of Pediatrics&Adolescent Medicine  finds that 14.2 percent of teenage children with any mental disorder have been treated with a psychotropic medication in the last 12 months, which researchers suggest challenges concern ...

Article - News Staff - Dec 4 2012 - 2:30pm

Largest Safety Trial Of Erwinaze To Date For Acute Lymphoblastic Leukemia

...

Article - News Staff - Dec 10 2012 - 9:53pm

Anabolic Androgenic Steroid Use Impacts Visuospatial Memory

The ability to accurately recall the shapes and spatial relationships of objects has been shown to be reduced by long-term use of anabolic-androgenic steroids (AAS), according to a recent paper.  ...

Article - News Staff - Dec 17 2012 - 4:31am

Phase I Trial For Pharmacokinetics Of KU-046 In Alzheimer's Disease

Kareus Therapeutics SA has announced the start of a Phase I clinical study following the Investigational New Drug (IND) approval from the US Food and Drug Administration for the development of KU-046, a first-in-class disease modifying new chemical entity ...

Article - News Staff - Jan 5 2013 - 9:30am

Phase 3 Registration Trial In Mildly Infected Diabetic Foot Ulcers With Locilex

...

Article - News Staff - Jan 4 2013 - 9:30am

FDA Approves Rebif Rebidose Interferon Beta-1a For Multiple Sclerosis

Merck Serono, a division of Germany's Merck, announced that the U.S. Food and Drug Administration (FDA) approved Rebif(R) Rebidose(R) (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used ...

Article - News Staff - Jan 3 2013 - 11:01am